Metabolic effects of obesity causing disease in childhood

Pamela Abrams1, Lorraine E Levitt Katz

  • 1Division of Endocrinology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. abramsp@email.chop.edu

Insights

Childhood obesity leads to serious metabolic diseases like type 2 diabetes and fatty liver disease in children. Early screening is crucial to detect and manage these conditions, preventing long-term adult health problems.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Childhood obesity is a global epidemic with increasing prevalence.
  • Long-term health consequences are a major concern for adult life.

Purpose of the Study:

  • To review the metabolic consequences of obesity manifesting during childhood.
  • To highlight diseases that can occur in obese children.

Main Methods:

  • Literature review of studies on childhood obesity and metabolic diseases.
  • Analysis of current research on the clinical presentation of obesity-related conditions in children.

Main Results:

  • Obese children exhibit adult-onset diseases including type 2 diabetes mellitus and potential beta-cell dysfunction.
  • Non-alcoholic fatty liver disease (NAFLD), steatohepatitis, and cirrhosis are prevalent in obese youth.
  • Central adiposity is linked to metabolic syndrome, characterized by insulin resistance, hypertension, and dyslipidemia, alongside hyperandrogenism and orthopedic issues.

Conclusions:

  • Physicians must inform families about both immediate and long-term risks of childhood obesity.
  • Screening for existing metabolic diseases in obese children is essential for timely intervention.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.